Plus   Neg

Clariant Q1 Continuing Operations EBITDA, Sales Decline - Quick Facts

Specialty chemicals company Clariant AG (CLZNY.PK,CRN.L,CLZNF.PK) on Thursday reported a 14 percent decline in its continuing operations EBITDA for the first quarter to 157 million Swiss francs from a restated 183 million francs in the year-ago period.

The company noted that the decline in EBITDA reflects lower sales due to the weak Aviation business in Care Chemicals, softer profitability in Catalysis due to lower sales as well as currency effects.

EBITDA margin was 15.4 percent in the quarter, compared to 15.7 percent in the year-ago period.

EBITDA before exceptional items declined 16 percent to 163 francs from 193 francs last year. EBITDA margin before exceptional items was 16.0 percent compared to 16.6 percent last year.

Clariant reported first-quarter sales from continuing operations of 1.02 billion francs, down 12 percent from 1.16 billion francs in the year-ago quarter. Sales declined 6 percent in local currencies.

The Group said it was confronted by a lower demand environment in the quarter amid a mild winter season and the COVID-19 pandemic.

Looking at 2020, Clariant anticipates a negative impact on sales and profitability from the COVID-19 pandemic, with the impact expected to more strongly affect the second quarter of 2020.

In the mid-term, Clariant expects its continuing businesses to achieve above-market growth, higher profitability and stronger cash generation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT